Table 2 Analysis of breast cancer specific survival and time to relapse in the whole group of patients by Cox regression
From: Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
Variable | n | Breast cancer specific survival | Time to relapse | ||
|---|---|---|---|---|---|
| Â | Â | HR (95% CI) | p-value | HR (95%CI) | p-value |
Age | Â | Â | Â | Â | Â |
 <=55 | 172 |  |  |  |  |
 >55 | 183 | 0.948 (0.638-1.408) | 0.791 | 0.993 (0.698-1.413) | 0.969 |
GASC1 status | Â | Â | Â | Â | Â |
 positive | 157 |  |  |  |  |
 negative | 198 | 2.040 (1.345-3.092) | 0.001 | 1.766 (1.230-2.535) | 0.002 |
Nodal status | Â | Â | Â | Â | Â |
 negative | 193 |  |  |  |  |
 positive | 162 | 3.177 (1.768-5.710) | 0.000 | 2.835 (1.702-4.723) | 0.000 |
Tumor size | Â | Â | Â | Â | Â |
 T1 | 168 |  |  |  |  |
 T2+T3+T4 | 187 | 0.621 (0.356-1.080) | 0.092 | 0.707 (0.431-1.161) | 0.171 |
Clinical stage | Â | Â | Â | Â | Â |
 I | 120 |  |  |  |  |
 II+III+IV | 230 | 1.107 (0.456-2.687) | 0.823 | 1.092 (0.511-2.335) | 0.820 |
 unknown | 5 |  |  |  |  |